Literature DB >> 11207028

Inhibition of cytochrome P450 2C9 activity in vitro by 5-hydroxytryptamine and adrenaline.

G Gervasini1, C Martínez, J A Agúndez, F J García-Gamito, J Benítez.   

Abstract

In the present study, the occurrence of a modulatory effect of 14 neurotransmitters, precursors and metabolites on the cytochrome P450 2C9 (CYP2C9) enzyme activity, as determined by diclofenac 4-hydroxylation, was studied in human liver microsomes. Two indoleamines, 5-hydroxytryptamine (5-HT) and adrenaline, showed a non-competitive-type inhibitory effect of approximately 90% of the diclofenac 4-hydroxylase activity, with Ki values of 63.5 (0.7 and 156 (89.3 microM, respectively. The rest of substances analysed were weak inhibitors or had no inhibitory effect. CYP2C subfamily is present in human brain, although CYP2C9 isozyme has not yet been identified in this tissue, and CYP2C9 is involved in the metabolism of psychoactive drugs. Therefore, the fact that endogenous compounds could modulate the CYP2C9 activity, suggests that an hypothetical local activity of brain CYP2C9 might be susceptible to regulatory mechanisms. The possible clinical implications of this modulation are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11207028     DOI: 10.1097/00008571-200102000-00004

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  7 in total

Review 1.  Drug-metabolizing cytochrome P450s in the brain.

Authors:  Sharon L Miksys; Rachel F Tyndale
Journal:  J Psychiatry Neurosci       Date:  2002-11       Impact factor: 6.186

2.  Novel drug metabolism indices for pharmacogenetic functional status based on combinatory genotyping of CYP2C9, CYP2C19 and CYP2D6 genes.

Authors:  David Villagra; John Goethe; Harold I Schwartz; Bonnie Szarek; Mohan Kocherla; Krystyna Gorowski; Andreas Windemuth; Gualberto Ruaño
Journal:  Biomark Med       Date:  2011-08       Impact factor: 2.851

Review 3.  Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity.

Authors:  Siamak Cyrus Khojasteh; Saileta Prabhu; Jane R Kenny; Jason S Halladay; Anthony Y H Lu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-02-19       Impact factor: 2.441

4.  5-Hydroxytryptamine is biotransformed by CYP2C9, 2C19 and 2B6 to hydroxylamine, which is converted into nitric oxide.

Authors:  Caroline Fradette; Nobuharu Yamaguchi; Patrick Du Souich
Journal:  Br J Pharmacol       Date:  2004-01-12       Impact factor: 8.739

Review 5.  Potential role of cerebral cytochrome P450 in clinical pharmacokinetics: modulation by endogenous compounds.

Authors:  Guillermo Gervasini; Juan Antonio Carrillo; Julio Benitez
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

6.  Comparative cytochrome p450 in vitro inhibition by atypical antipsychotic drugs.

Authors:  Guillermo Gervasini; Maria J Caballero; Juan A Carrillo; Julio Benitez
Journal:  ISRN Pharmacol       Date:  2013-02-13

7.  Mechanisms of modafinil: A review of current research.

Authors:  Paul Gerrard; Robert Malcolm
Journal:  Neuropsychiatr Dis Treat       Date:  2007-06       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.